Management of fetal hydrops associated with parvovirus B19 infection
- 1 December 1994
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 101 (12) , 1079-1081
- https://doi.org/10.1111/j.1471-0528.1994.tb13586.x
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Parvovirus B19 infection and transient fetal hydropsThe Lancet, 1991
- Prospective study of human parvovirus (B19) infection in pregnancy. Public Health Laboratory Service Working Party on Fifth Disease.BMJ, 1990
- Antenatal diagnosis and palliative treatment of non‐immune hydrops fetalis secondary to fetal parvovirus B19 infectionPrenatal Diagnosis, 1989
- HUMAN PARVOVIRUS B19 INFECTION IN PREGNANCYThe Lancet, 1988
- B19 PARVOVIRUS INFECTION OF MYOCARDIAL CELLSThe Lancet, 1988
- PARVOVIRUS B19 ASSOCIATED WITH FETAL ABNORMALITYThe Lancet, 1987
- MATERNAL SERUM α-FETOPROTEIN—A MARKER OF FETAL APLASTIC CRISIS DURING INTRAUTERINE HUMAN PARVOVIRUS INFECTIONThe Lancet, 1987
- Human Parvovirus Infection in Pregnancy and Hydrops FetalisNew England Journal of Medicine, 1987
- INTRAUTERINE PARVOVIRUS INFECTION ASSOCIATED WITH HYDROPS FETALISThe Lancet, 1984